Daniel Shapiro/X
Nov 2, 2024, 20:51
Daniel Shapiro: Our editorial regarding perioperative trials in RCC
Daniel Shapiro, Urologic Oncologist at UW Urology, shared a post on X by Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, about a recent paper by them published in Science Direct.
“Happy to see our editorial European Urology regarding perioperative trials in RCC. Difficult to risk stratify patients in this space accurately to achieve sufficient number of events and power to detect treatment effect.”
Quoting Pavlos Msaouel’s post:
“Commentary European Urology led by Daniel Shapiro on how the observed adjuvant immunotherapy trial result discrepancies in kidney cancer can be explained by simple trial design principles.”
Authors: Daniel Shapiro, Pavlos Msaoul
More posts featuring Daniel Shapiro.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19